L086-1303 Screening compound: 4-tert-butyl-N-[(E)-N'-(3,4-dimethoxyphenyl)-N-[(pyridin-2-yl)methyl]carbamimidoyl]benzamide

L086-1303 Screening compound: 4-tert-butyl-N-[(E)-N'-(3,4-dimethoxyphenyl)-N-[(pyridin-2-yl)methyl]carbamimidoyl]benzamide
L086-1303 Screening compound: 4-tert-butyl-N-[(E)-N'-(3,4-dimethoxyphenyl)-N-[(pyridin-2-yl)methyl]carbamimidoyl]benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L086-1303
4-tert-butyl-N-[(E)-N'-(3,4-dimethoxyphenyl)-N-[(pyridin-2-yl)methyl]carbamimidoyl]benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L086-1303

Molecular Formula

C26H30N4O3 (C26 H30 N4 O3)

Compound Name

4-tert-butyl-N-[(E)-N'-(3,4-dimethoxyphenyl)-N-[(pyridin-2-yl)methyl]carbamimidoyl]benzamide

IUPAC name

4-tert-butyl-N-[(E)-N'-(34-dimethoxyphenyl)-N-[(pyridin-2-yl)methyl]carbamimidoyl]benzamide

SMILES

CC(C)(C)c(cc1)ccc1C(N/C(/NCc1ncccc1)=N/c(cc1)cc(OC)c1OC)=O

InChI

InChI=1S/C26H30N4O3/c1-26(2,3)19-11-9-18(10-12-19)24(31)30-25(28-17-21-8-6-7-15-27-21)29-20-13-14-22(32-4)23(16-20)33-5/h6-16H,17H2,1-5H3,(H2,28,29,30,31)

InChI Key

MMUIADBLONZETQ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27230182

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

446.55

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.564

Distribution Coefficient, logD

3.784

Water Solubility, LogSw

-4.35

Polar Surface Area

66.655

Acid Dissociation Constant (pKa)

11.03

Base Dissociation Constant (pKb)

8.10

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

26.90

L086-1303 in Drug Discovery

Included in Screening Libraries

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with L086-1303 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L086-1303?
Check Price and Availability of L086-1303, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L086-1303 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L086-1303
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L086-1303
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L086-1303 available by request